NCK Pharma » Knowledge Base

15 Sep 2020

Case Study – Strategic Insight on Gilead and Immunomedics $21 Billion Deal

Posted Byadmin

Comments0

Gilead Sciences Inc. agreed to acquire Immunomedics Inc. for about $21 billion, a substantial premium for the maker of a...

15 Sep 2020

Insight on USFDA approval of pralsetinib to treat non-small lung cancer

Posted Byadmin

Comments0

TagsBlueprint Medicines Corporation, pralsetinib

Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that...

15 Sep 2020

What is hybrid clinical trial?

Posted Byadmin

Comments0

A hybrid trial is a type of clinical trial which includes both traditional and pragmatic clinical trial elements. Randomized controlled trials...

15 Sep 2020

Strides Pharma to acquire 54% stake in SteriScience

Posted Byadmin

Comments0

Tagsacquisition in pharma, Strides Arcolab, strides aspen, Strides Shasun

Strides Pharma Science will invest Rs 135 crore over the next 24 months to acquire around 54 percent stake in...

15 Sep 2020

Aurobindo Pharma partners with BIRAC to develop Covid-19 vaccine

Posted Byadmin

Comments0

TagsAurobindo, covi9 19 vaccine, COVID-19

Aurobindo Pharma is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based...

11 Aug 2020

Insight on First approved COVID-19 vaccine Sputnik V

Posted Byadmin

Comments0

TagsCOVID-19, Gamaleya National Research Centre, nCoV-19 vaccine, Sputnik V

Russia has announced the launch of first approved covid-19 vaccine. The Covid-19 vaccine brand name is Sputnik V. Sputnik V...

7 Aug 2020

Novavax and Serum Institute of India – licensing agreement for Development and Commercial Collaboration

Posted Byadmin

Comments0

TagsCOVID-19, nCoV-19 vaccine, Novavax, serum institute

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced a license agreement with Serum...

7 Aug 2020

Novavax reports positive results from phase 1 trial of COVID-19 vaccine candidate, NVX-CoV2373 with Matrix-M

Posted Byadmin

Comments0

TagsCOVID-19, nCoV-19 vaccine

Novavax, a late-stage biotechnology company, announced phase 1 data from its phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID-19...

7 Aug 2020

Lupin gets exclusive rights to market and distribute 2 complex injectable assets from ForDoz Pharma

Posted Byadmin

Comments0

TagsForDoz Pharma, inlicensing in pharma, Lupin

Pharma major Lupin Limited announced that its US based wholly-owned subsidiary Lupin Pharmaceuticals Inc., has entered into an agreement with...

7 Aug 2020

Biotricity receives US FDA 510(k) clearance for Bioflux software II system

Posted Byadmin

Comments0

Tags510(k), Medical device approval

Biotricity, a medical diagnostic and consumer healthcare technology company, announced that it has received a 510(k) clearance from the FDA...

7 Aug 2020

Cofsils brand expansion with face masks launch

Posted Byadmin

Comments0

TagsCofsils

Cofsils, a leading brand under Cipla Health Ltd., which offers a complete solution for sore throat and cough related issues,...

7 Aug 2020

Zydus Cadila’s ZyCoV-D in Phase II clinical trials for COVID-19

Posted Byadmin

Comments0

TagsCOVID-19, nCoV-19 vaccine, ZyCoV-D

Zydus Cadila’s ZyCoV-D is the plasmid DNA vaccine to prevent COVID-19. ZyCoV-D was found to be safe and well tolerated...

28 Jul 2020

Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA

Posted Byadmin

Comments0

Tagsdrug licensing, licensing deal in pharma

Lynk Pharmaceuticals (Hangzhou, China) is pleased to announce exclusive licensing agreements with Kobe University (Kobe, Japan) and with RIKEN Research...

28 Jul 2020

Novavax, FDB agreement for large scale manufacturing of COVID-19 vaccine candidate

Posted Byadmin

Comments0

TagsFUJIFILM Diosynth Biotechnologies, influenza vaccine, nCoV-19 vaccine, Novavax

NovavaxInc, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and FUJIFILM Diosynth Biotechnologies (FDB), a world leading...

28 Jul 2020

Pfizer-BioNTech agreement with U.S. Gov for up to 600 million doses of mRNA-based vaccine aandidate against SARS-CoV-2

Posted Byadmin

Comments0

TagsBioNTech, COVID-19, pfizer

Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services...

28 Jul 2020

Insight on Novartis’s first-of-its-kind not-for-profit medicine portfolio for symptomatic treatment of COVID-19

Posted Byadmin

Comments0

TagsCOVID-19, nCoV-19 vaccine, novartis, sandoz

Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat...

21 Jul 2020

Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million doses of their BNT162 mRNA-based SARS-CoV-2 vaccine

Posted Byadmin

Comments0

TagsBioNTech, COVID-19, nCoV-19 vaccine, pfizer

Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million doses of their BNT162 mRNA-based vaccine...

21 Jul 2020

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial published in The Lancet Journal

Posted Byadmin

Comments0

Tagscovi9 19 vaccine, COVID-19, nCoV-19 vaccine

ChAdOx1 Covid-19 vaccine in clinical study The Oxford shot is one of the front runners in the vaccine race and...

11 Jul 2020

DCGI approved Itolizumab to treat COVID-19 patients with moderate to severe acute respiratory distress

Posted Byadmin

Comments0

TagsBiocon, Itolizumab

India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for “restricted emergency use” to treat...

5 Jun 2020

Aurobindo Pharma hives off its biosimilars business to subsidiary CuraTeQ Biologics

Posted Byadmin

Comments0

TagsAurobindo, Biosimilar, CuraTeQ Biologics

Aurobindo Pharma hives off its biosimilars business to wholy-owned subsidiary ‘CuraTeQ Biologics Private Limited’ for a cash consideration of ₹361.46...

5 Jun 2020

Lupin, Mylan receive EUmarketing authorization for Nepexto

Posted Byadmin

Comments0

Lupin Limited (Lupin) and Mylan N.V. announced that the European Commission (EC) has granted marketing authorization for Nepexto, a biosimilar...

5 Jun 2020

AstraZeneca, Accent Therapeutics partners to develop transformative therapeutics targeting RMPs to treat cancer

Posted Byadmin

Comments0

TagsAccent Therapeutics, AstraZeneca, codevelopment deal in pharma

Accent Therapeutics and AstraZeneca forged a collaboration valued at about $1.1 billion to discover, develop and commercialize transformative therapeutics targeting...

5 Jun 2020

Roche’s Elecsys IL-6 test received USFDA EUA

Posted Byadmin

Comments0

TagsCOVID-19, Roche, USFDA emergency use authorization

Roche announced that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorisation (EUA) for the Elecsys...

13 May 2020

Gilead’s Voluntary Licensing Agreements for Remdesivir with 5 generic companies

Posted Byadmin

Comments0

Tagsdrug licensing, gilead, global pharma licensing deal, licensing deal in pharma, mylan licensing deal, nonexclusive, Remdesivir

Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand supply...

7 May 2020

Market Exclusivity Case Study: XIFAXAN (rifaximin)

Posted Byadmin

Comments0

Tags505(j) ANDA, ANDA, Bausch, MARKET EXCLUSIVITY, Patent infringement case, sandoz

Bausch Health Companies Inc. along with its wholly owned subsidiary, Salix Pharmaceuticals, which is one of the largest specialty pharmaceutical...

7 May 2020

FDA Grants Accelerated Approval to Capmatinib for NSCLC

Posted Byadmin

Comments0

The FDA granted accelerated approval to capmatinib (Tabrecta) for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors...

7 May 2020

Aleor Dermaceuticals receives EIR from US FDA for Karakhadi formulation facility

Posted Byadmin

Comments0

Tags483, 483 observations, Alembic, Aleor Dermaceuticals, EIR

Aleor Dermaceuticals Ltd. (Aleor), a 60:40 joint venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular),...

7 May 2020

Lupin introduces ‘Jan Kovid’ helpline for Mumbai citizens

Posted Byadmin

Comments0

Lupin has announced the launch of the ‘Jan Kovid’ Helpline (1800-572-6130) under the tagline ‘Mann Ka Swaasthya, Tann Ki Suraksha’ for...

7 May 2020

Bausch + Lomb – Stada Arzneimittel – Xbrane Biopharma – licensing deal for Lucentis biosimilar

Posted Byadmin

Comments0

TagsBausch + Lomb, Ranibizumab, Ranibizumab biosimilar, Stada, Xbrane Signs Deal With Helvetic BioPharma for its Lead Ranibizumab Biosimilar

Bausch + Lomb announced an exclusive licensing agreement with Stada Arzneimittel and its development partner Xbrane Biopharma to develop and...

5 May 2020

Valneva And Pfizer to Co-Develop and Commercialize Lyme Disease Vaccine, Vla15

Posted Byadmin

Comments0

Tagspfizer, Valneva

Valneva SE, a specialty vaccine company, and Pfizer Inc. today announced a collaboration to develop and commercialize Valneva’s Lyme disease...

Recently Published Articles

Case Study – Strategic Insight on Gilead and Immunomedics $21 Billion Deal

Insight on USFDA approval of pralsetinib to treat non-small lung cancer

What is hybrid clinical trial?

Strides Pharma to acquire 54% stake in SteriScience

Aurobindo Pharma partners with BIRAC to develop Covid-19 vaccine

Insight on First approved COVID-19 vaccine Sputnik V

Novavax and Serum Institute of India – licensing agreement for Development and Commercial Collaboration

Novavax reports positive results from phase 1 trial of COVID-19 vaccine candidate, NVX-CoV2373 with Matrix-M

Lupin gets exclusive rights to market and distribute 2 complex injectable assets from ForDoz Pharma

Biotricity receives US FDA 510(k) clearance for Bioflux software II system

Cofsils brand expansion with face masks launch

Zydus Cadila’s ZyCoV-D in Phase II clinical trials for COVID-19

Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA

Novavax, FDB agreement for large scale manufacturing of COVID-19 vaccine candidate

Pfizer-BioNTech agreement with U.S. Gov for up to 600 million doses of mRNA-based vaccine aandidate against SARS-CoV-2

Insight on Novartis’s first-of-its-kind not-for-profit medicine portfolio for symptomatic treatment of COVID-19

Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million doses of their BNT162 mRNA-based SARS-CoV-2 vaccine

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial published in The Lancet Journal

DCGI approved Itolizumab to treat COVID-19 patients with moderate to severe acute respiratory distress

Aurobindo Pharma hives off its biosimilars business to subsidiary CuraTeQ Biologics

Lupin, Mylan receive EUmarketing authorization for Nepexto

AstraZeneca, Accent Therapeutics partners to develop transformative therapeutics targeting RMPs to treat cancer

Roche’s Elecsys IL-6 test received USFDA EUA

Gilead’s Voluntary Licensing Agreements for Remdesivir with 5 generic companies

Market Exclusivity Case Study: XIFAXAN (rifaximin)

FDA Grants Accelerated Approval to Capmatinib for NSCLC

Aleor Dermaceuticals receives EIR from US FDA for Karakhadi formulation facility

Lupin introduces ‘Jan Kovid’ helpline for Mumbai citizens

Bausch + Lomb – Stada Arzneimittel – Xbrane Biopharma – licensing deal for Lucentis biosimilar

Valneva And Pfizer to Co-Develop and Commercialize Lyme Disease Vaccine, Vla15

Certification Courses

Corporate Training

Your form has been submitted

Server Side Error

Error